MicroRNAs as Novel Biomarkers for P2Y12 – Inhibitors Resistance Prediction-Reference-Cited by-同舟云学术

MicroRNAs as Novel Biomarkers for P2Y12 – Inhibitors Resistance Prediction

Published:2021-12 Issue: Volume:Volume 14 Page:1575-1582
ISSN:1178-7066
Container-title:Pharmacogenomics and Personalized Medicine
language:en
Short-container-title:PGPM

Author:

Rytkin Eric^ORCID,Mirzaev Karin,Bure Irina,Akmalova Kristina^ORCID,Abdullaev Sherzod,Kachanova Anastasia,Smirnov Valery,Grishina Elena,Lyakhova Nataliya,Aleshkovich Elena,Saribekian Anna,Andreev Denis^ORCID,Shabunin Alexey,Sychev Dmitry

Publisher

Informa UK Limited

Subject

Pharmacology,Molecular Medicine

Reference40 articles.

1. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

2. Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update

3. Genetic Determinants of Response to Clopidogrel and Cardiovascular Events

4. Clopidogrel Response Variability and Future Therapies

5. A prospective randomized evaluation of a pharmacogenomic approach to antiplatelet therapy among patients with ST-elevation myocardial infarction: the RAPID STEMI study

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospects for the development of pharmacogenetics in Russia for the personalization of pharmacotherapy;Russian Journal for Personalized Medicine;2023-11-23

2. Influence of Genetic and Epigenetic Factors of P2Y12 Receptor on the Safety and Efficacy of Antiplatelet Drugs;Cardiovascular Drugs and Therapy;2022-08-09

3. Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic Target;Frontiers in Cardiovascular Medicine;2022-06-09

4. MicroRNA 320a and Membrane Antigens as Tools to Evaluate the Pathophysiology of Platelets Stored in Blood Banks;Current Issues in Molecular Biology;2022-04-22